Proniras Corporation, an Accelerator Life Science Partners portfolio company, announced on 4/27/18 that it has been awarded a contract potentially worth $89.5 million from the U.S. Department of... read more
Proniras Corporation, an Accelerator Life Science Partners portfolio company, announced on 4/27/18 that it has been awarded a contract potentially worth $89.5 million from the U.S. Department of... read more
ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the... read more
Innovent Biologics, Inc., announced the completion of its US$150 million Series E round financing.
This round of financing attracted high quality global institutional investors and... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,